Related Experiment Video
Updated: Jan 11, 2026

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
Lipoprotein (a) as a risk factor for prosthetic heart valve thrombosis
Mahmut Yesin1, Macit Kalçık2, Emrah Bayam3
1Department of Cardiology, VM Medicalpark Hospital, Ovacık, D100 Üstü No:34, 41140, Başiskele, Kocaeli, Turkey. mahmutyesin@yahoo.com.
Insights
Elevated lipoprotein (a) [Lp(a)] levels are significantly higher in patients with mechanical prosthetic valve thrombosis (MPVT). This finding suggests Lp(a) may be an independent predictor of MPVT and cerebrovascular accidents (CVA).
Area of Science:
- Cardiovascular Medicine
- Clinical Chemistry
- Thrombosis Research
Background:
- Lipoprotein (a) [Lp(a)] is a known risk factor for atherothrombotic diseases.
- Lp(a) shares structural similarities with plasminogen, potentially impairing fibrinolysis and promoting thrombogenesis.
- Elevated Lp(a) is implicated in various cardiovascular conditions.
Purpose of the Study:
- To investigate and compare lipoprotein (a) [Lp(a)] levels in patients with mechanical prosthetic valve thrombosis (MPVT) versus controls.
- To identify independent predictors of MPVT, including Lp(a) levels.
- To explore the association between Lp(a) levels and a history of cerebrovascular accidents (CVA) in MPVT patients.
Main Methods:
- A cross-sectional study involving 80 MPVT patients and 75 age/sex-matched controls with normally functioning mechanical prosthetic valves.
- Plasma samples were collected for the determination of lipoprotein (a) [Lp(a)] levels.
- Statistical analysis was performed to compare Lp(a) levels and identify independent predictors of MPVT, including logistic regression and ROC curve analysis.
Main Results:
- Patients with MPVT exhibited significantly higher Lp(a) levels compared to controls (22 vs. 6.9 mg/dL, p < 0.001).
- Elevated Lp(a), subtherapeutic anticoagulation, prior CVA, and low international normalized ratio were independent predictors of MPVT.
- Lp(a) levels above 19.6 mg/dL predicted MPVT with 65% sensitivity and 71% specificity (AUC: 0.767).
- MPVT patients with a history of CVA had significantly higher Lp(a) levels (42.0 vs. 21.1 mg/dL, p = 0.012).
Conclusions:
- Elevated lipoprotein (a) [Lp(a)] levels are significantly associated with mechanical prosthetic valve thrombosis (MPVT).
- Plasma Lp(a) may serve as an independent predictor for MPVT and related cerebrovascular events (CVA).
- Measuring Lp(a) in patients with prosthetic heart valves could offer valuable risk stratification for PVT and CVA.
Abstract:
Genetic and numerous epidemiologic studies have identified lipoprotein (a) [Lp(a)] as a risk factor for atherothrombotic diseases. The structure of Lp(a) is similar to plasminogen and tissue plasminogen activator and it competes with plasminogen for its binding site, leading to reduced fibrinolysis. Furthermore, since Lp(a) stimulates the secretion of plasminogen activator inhibitor-1, it may lead to thrombogenesis. In this cross-sectional study, we aimed to investigate Lp(a) levels in patients with mechanical prosthetic valve thrombosis (MPVT). Blood samples for Lp(a) determination were obtained from 80 MPVT patients (median age: 48.5 (39-59.75) years; 47 male) and 75 age and sex matched controls (median age: 52 (39-63) years; 44 male) with normally functioning mechanical prosthetic valves. The Lp(a) levels in the PVT group were significantly higher than in the controls [22(16.2-39.4) vs. 6.9(2.9-24.6) mg/dL, p < 0.001]. Elevated Lp(a) levels, recent history of subtherapeutic anticoagulation, history of cerebrovascular accidents (CVA) and a low value of international normalized ratio on admission were found to be the independent predictors of PVT. Lp(a) levels above 19.6 mg/dL predicted PVT with a sensitivity of 65% and a specificity of 71% (AUC:0.767; 95%CI: 0.687 to 0.847; p < 0.001). Lp(a) levels were significantly higher in PVT patients with a history of CVA [42.0 (23.6-53.6) vs. 21.1 (16.1- 36.2) mg/dL, p = 0.012]. Elevated Lp(a) levels may be associated with MPVT. The assessment of plasma Lp(a) levels in patients with prosthetic heart valves may provide additive information regarding the risk of PVT and CVA.
Related Concept Videos
Atherosclerosis I: Introduction
Mitral Valve Prolapse I: Introduction
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Peripheral Artery Disease I: Introduction
Venous Thrombosis I: Introduction
Lipid-Lowering Drugs: Statins and Miscellaneous Agents

